Posted in M&A / Deals UCB to purchase Neurona and NRTX-1001 for $1.15bn April 20, 2026 Pharmaceutical Business Review The deal value comprises an upfront payment of up to $650m and up to $500m in future milestones. M&A / DealsNeuroscienceRead full story